| Literature DB >> 18974104 |
Kimberly J Briggs1, Charles G Eberhart, D Neil Watkins.
Abstract
Hypermethylated in cancer-1 (HIC1) is a tumor suppressor frequently targeted for promoter hypermethylation in medulloblastoma, an embryonal tumor of the cerebellum. Recently, we showed that HIC1 is a direct transcriptional repressor of ATOH1, a proneural transcription factor required for normal cerebellar development, as well as for medulloblastoma cell viability. Because demethylating agents can induce reexpression of silenced tumor suppressors, restoring HIC1 function may present an attractive therapeutic avenue in medulloblastoma by exploiting an apparent addiction to ATOH1.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18974104 PMCID: PMC2702666 DOI: 10.1158/0008-5472.CAN-08-1904
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701